- Home
- ECVT vs PRGO Comparison
ECVT vs PRGO Comparison
Compare ECVT & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ECVT | PRGO |
|---|---|---|
| Founded | 1935 | 1887 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.6B |
| IPO Year | 2017 | 2013 |
Fundamental Metrics
Financial Performance| Metric | ECVT | PRGO |
|---|---|---|
| Price | $12.97 | $10.70 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 3 |
| Target Price | $14.00 | ★ $19.33 |
| AVG Volume (30 Days) | 1.7M | ★ 3.0M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 10.28% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.04 | N/A |
| Revenue | ★ $723,515,000.00 | $800,000.00 |
| Revenue This Year | $29.07 | N/A |
| Revenue Next Year | $6.71 | $1.02 |
| P/E Ratio | $327.25 | ★ N/A |
| Revenue Growth | ★ 2.70 | N/A |
| 52 Week Low | $7.39 | $9.23 |
| 52 Week High | $15.09 | $28.44 |
Technical Indicators
Market Signals| Indicator | ECVT | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 43.04 | 44.40 |
| Support Level | $12.74 | $10.37 |
| Resistance Level | $15.01 | $11.88 |
| Average True Range (ATR) | 0.33 | 0.57 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 34.04 | 25.57 |
Price Performance
Historical ComparisonAbout ECVT Ecovyst Inc.
Ecovyst Inc is an integrated and provider of materials, specialty catalysts and services. Its products contribute to lower emissions and cleaner air, higher fuel efficiency and cleaner fuels, and key enablers to advance transition to clean energy. The company has one operating segment. The Company's single reportable segment, Ecoservices, derives its revenue through the sale of virgin and regenerated sulfuric acid products and services.
About PRGO Perrigo Company plc
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.